Top

Published in:

Open Access 01-11-2018 | Review

Setting the stage for a role of the postsynaptic proteome in inherited neurometabolic disorders

Author: Àlex Bayés

Published in: Journal of Inherited Metabolic Disease | Issue 6/2018

Abstract

Neurotransmitter diseases are a well-defined group of metabolic conditions caused, in most instances, by genes specifically expressed in the presynaptic button. Better understanding of presynaptic molecular physiology, both in normal and pathological conditions, should help develop therapeutical strategies. The clinical relevance of the presynapse in inherited metabolic disorders is in glaring contrast with that of the postsynaptic component, which so far does not seem to play a relevant role in these disorders. This is somewhat surprising, as postsynaptic proteins are known to be involved in many nervous system diseases, particularly in neurodevelopmental and psychiatric disorders. The goal of this article is to explore if defects in the sophisticated postsynaptic machinery could also have a role in neurometabolic disorders.

Available only for authorised users

Anggono V, Huganir RL (2012) Regulation of AMPA receptor trafficking and synaptic plasticity. Curr Opin Neurobiol. https://doi.org/10.1016/j.conb.2011.12.006

Ashrafi G, Wu Z, Farrell RJ, Ryan TA (2017) GLUT4 mobilization supports energetic demands of active synapses. Neuron 93:606–615.e3. https://doi.org/10.1016/j.neuron.2016.12.020 CrossRefPubMedPubMedCentral

Attwell D, Laughlin SB (2001) An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab 21:1133–1145. https://doi.org/10.1097/00004647-200110000-00001 CrossRefPubMed

Bayés A, Grant SGN (2009) Neuroproteomics: understanding the molecular organization and complexity of the brain. Nat Rev Neurosci 10:635–646. https://doi.org/10.1038/nrn2701 CrossRefPubMed

Bayés A, Van De Lagemaat LN, Collins MO et al (2011) Characterization of the proteome, diseases and evolution of the human postsynaptic density. Nat Neurosci 14:19–21. https://doi.org/10.1038/nn.2719 CrossRefPubMed

Bayés A, Collins MO, Croning MDR et al (2012) Comparative study of human and mouse postsynaptic proteomes finds high compositional conservation and abundance differences for key synaptic proteins. PLoS One 7:e46683. https://doi.org/10.1371/journal.pone.0046683 CrossRefPubMedPubMedCentral

Bayés A, Collins MO, Galtrey CM et al (2014) Human post-mortem synapse proteome integrity screening for proteomic studies of postsynaptic complexes. Mol Brain 7:635. https://doi.org/10.1186/s13041-014-0088-4 CrossRef

Bayés À, Collins MO, Reig-Viader R et al (2017) Evolution of complexity in the zebrafish synapse proteome. Nat Commun 8:1–15. https://doi.org/10.1038/ncomms14613 CrossRef

Beaulieu C, Colonnier M (1985) A laminar analysis of the number of round-asymmetrical and flat-symmetrical synapses on spines, dendritic trunks, and cell bodies in area 17 of the cat. J Comp Neurol 231:180–189. https://doi.org/10.1002/cne.902310206 CrossRefPubMed

Berkel S, Marshall CR, Weiss B et al (2010) Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat Genet 42:489–491. https://doi.org/10.1038/ng.589 CrossRefPubMed

Billuart P, Bienvenu T, Ronce N et al (1998) Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation. Nature 392:923–926. https://doi.org/10.1038/31940 CrossRefPubMed

Bingol B, Schuman EM (2006) Activity-dependent dynamics and sequestration of proteasomes in dendritic spines. Nature 441:1144–1148. https://doi.org/10.1038/nature04769 CrossRefPubMed

Boeckers TM (2006) The postsynaptic density. Cell Tissue Res 326:409–422. https://doi.org/10.1007/s00441-006-0274-5 CrossRefPubMed

Brose N, O’Connor V, Skehel P (2010) Synaptopathy: dysfunction of synaptic function? Biochem Soc Trans 38:443–444. https://doi.org/10.1042/BST0380443 CrossRefPubMed

Carlin RK, Grab DJ, Cohen RS, Siekevitz P (1980) Isolation and characterization of postsynaptic densities from various brain regions: enrichment of different types of postsynaptic densities. J Cell Biol 86:831–845CrossRefPubMed

Clement JP, Aceti M, Creson TK et al (2012) Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses. Cell 151:709–723. https://doi.org/10.1016/j.cell.2012.08.045 CrossRefPubMedPubMedCentral

Cortès-Saladelafont E, Tristán-Noguero A, Artuch R et al (2016) Diseases of the synaptic vesicle: a potential new group of neurometabolic disorders affecting neurotransmission. Semin Pediatr Neurol 23:306–320. https://doi.org/10.1016/j.spen.2016.11.005 CrossRefPubMed

De Robertis E, Bennett HS (1954) Submicroscopic vesicular component in the synapse. Fed Proc 13:35–42

Defelipe J, Alonso-Nanclares L, Arellano JI (2002) Microstructure of the neocortex: comparative aspects. J Neurocytol 31:299–316CrossRefPubMed

Distler U, Schmeisser MJ, Pelosi A et al (2014) In-depth protein profiling of the postsynaptic density from mouse hippocampus using data-independent acquisition proteomics. Proteomics 14:2607–2613CrossRefPubMed

Dosemeci A, Weinberg RJ, Reese TS, Tao-Cheng J-H (2016) The postsynaptic density: there is more than meets the eye. Front Synaptic Neurosci 8:23. https://doi.org/10.3389/fnsyn.2016.00023 CrossRefPubMedPubMedCentral

Ehlers MD (2003) Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat Neurosci 6:231–242CrossRefPubMed

Fabregat A, Jupe S, Matthews L et al (2018) The Reactome Pathway Knowledgebase. Nucleic Acids Res 46:D649–D655. https://doi.org/10.1093/nar/gkx1132 CrossRefPubMed

Fernandez E, Collins MO, Uren RT et al (2009) Targeted tandem affinity purification of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins. Mol Syst Biol 5:269. https://doi.org/10.1038/msb.2009.27 CrossRefPubMedPubMedCentral

Ferreira JM, Burnett AL, Rameau GA (2011) Activity-dependent regulation of surface glucose transporter-3. J Neurosci 31:1991–1999. https://doi.org/10.1523/JNEUROSCI.1850-09.2011 CrossRefPubMedPubMedCentral

Focking M, Dicker P, Lopez LM et al (2016) Proteomic analysis of the postsynaptic density implicates synaptic function and energy pathways in bipolar disorder. Transl Psychiatry 6:e959–e959. https://doi.org/10.1038/tp.2016.224 CrossRefPubMedPubMedCentral

Grant SG (2012) Synaptopathies: diseases of the synaptome. Curr Opin Neurobiol 22:522–529. https://doi.org/10.1016/j.conb.2012.02.002 CrossRefPubMed

Gray EG (1959) Electron microscopy of synaptic contacts on dendrite spines of the cerebral cortex. Nature 183:1592–1593CrossRefPubMed

Guilmatre A, Dubourg C, Mosca AL et al (2009) Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry 66:947–956. https://doi.org/10.1001/archgenpsychiatry.2009.80 CrossRefPubMedPubMedCentral

Guilmatre A, Huguet G, Delorme R, Bourgeron T (2014) The emerging role of SHANK genes in neuropsychiatric disorders. Dev Neurobiol 74:113–122. https://doi.org/10.1002/dneu.22128 CrossRefPubMed

Hamdan FF, Gauthier J, Spiegelman D et al (2009) Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. N Engl J Med 360:599–605CrossRefPubMedPubMedCentral

Hamdan FF, Gauthier J, Araki Y et al (2011) Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. Am J Hum Genet 88:306–316. https://doi.org/10.1016/j.ajhg.2011.02.001 CrossRefPubMedPubMedCentral

Harris JJ, Jolivet R, Attwell D (2012) Synaptic energy use and supply. Neuron 75:762–777. https://doi.org/10.1016/j.neuron.2012.08.019 CrossRefPubMed

Hoffman GF, Blau N (2014) Congenital neurotransmitter disorders: a clinical approach, 1st edn. Nova Science Publishers Inc., New York

Ikemoto A, Bole DG, Ueda T (2003) Glycolysis and glutamate accumulation into synaptic vesicles. J Biol Chem 278:5929–5940. https://doi.org/10.1016/S0896-6273(00)00098-2 CrossRefPubMed

Jang S, Nelson JC, Bend EG et al (2016) Glycolytic enzymes localize to synapses under energy stress to support synaptic function. Neuron 90:278–291. https://doi.org/10.1016/j.neuron.2016.03.011 CrossRefPubMedPubMedCentral

Jurcovicova J (2014) Glucose transport in brain - effect of inflammation. Endocr Regul 48:35–48CrossRefPubMed

Kim E, Sheng M (2009) The postsynaptic density. Curr Biol 19:R723–R724CrossRefPubMed

Kirov G, Pocklington AJ, Holmans P et al (2011) De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry 17:142–153. https://doi.org/10.1038/mp.2011.154 CrossRefPubMedPubMedCentral

Köhler S, Vasilevsky NA, Engelstad M et al (2017) The human phenotype ontology in 2017. Nucleic Acids Res 45:D865–D876. https://doi.org/10.1093/nar/gkw1039 CrossRefPubMed

Leblond CS, Heinrich J, Delorme R et al (2012) Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet 8:e1002521. https://doi.org/10.1371/journal.pgen.1002521 CrossRefPubMedPubMedCentral

Leino RL, Gerhart DZ, van Bueren AM et al (1997) Ultrastructural localization of GLUT 1 and GLUT 3 glucose transporters in rat brain. J Neurosci Res 49:617–626. https://doi.org/10.1002/(SICI)1097-4547(19970901)49:5<617::AID-JNR12>3.0.CO;2-S CrossRefPubMed

Li Z, Okamoto K-I, Hayashi Y, Sheng M (2004) The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119:873–887. https://doi.org/10.1016/j.cell.2004.11.003 CrossRefPubMed

Marecos C, Ng J, Kurian MA (2014) What is new for monoamine neurotransmitter disorders? J Inherit Metab Dis 37:619–626. https://doi.org/10.1007/s10545-014-9697-4 CrossRefPubMed

Martin KC, Barad M, Kandel ER (2000) Local protein synthesis and its role in synapse-specific plasticity. Curr Opin Neurobiol 10:587–592CrossRefPubMed

McKusick VA (2007) Mendelian inheritance in man and its online version, OMIM. Am J Hum Genet 80:588–604. https://doi.org/10.1086/514346 CrossRefPubMedPubMedCentral

Mi H, Poudel S, Muruganujan A et al (2016) PANTHER version 10: expanded protein families and functions, and analysis tools. Nucleic Acids Res 44:D336–D342. https://doi.org/10.1093/nar/gkv1194 CrossRefPubMed

Ng J, Papandreou A, Heales SJ, Kurian MA (2015) Monoamine neurotransmitter disorders-clinical advances and future perspectives. Nat Rev Neurol 11:567–584. https://doi.org/10.1038/nrneurol.2015.172 CrossRefPubMed

Ostroff LE, Fiala JC, Allwardt B, Harris KM (2002) Polyribosomes redistribute from dendritic shafts into spines with enlarged synapses during LTP in developing rat hippocampal slices. Neuron 35:535–545CrossRefPubMed

Palade GE, Palay SL (1954) Electron microscope observations of interneuronal and neuromuscular synapses. Anat Rec 118:335–336

Parente DJ, Garriga C, Baskin B et al (2017) Neuroligin 2 nonsense variant associated with anxiety, autism, intellectual disability, hyperphagia, and obesity. Am J Med Genet A 173:213–216. https://doi.org/10.1002/ajmg.a.37977 CrossRefPubMed

Pearl PL, Taylor JL, Trzcinski S, Sokohl A (2007) The pediatric neurotransmitter disorders. J Child Neurol 22:606–616. https://doi.org/10.1177/0883073807302619 CrossRefPubMed

Pearl PL, Gibson KM, Quezado Z et al (2009) Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiency. Neurology 73:423–429. https://doi.org/10.1212/WNL.0b013e3181b163a5 CrossRefPubMedPubMedCentral

Racz B, Blanpied TA, Ehlers MD, Weinberg RJ (2004) Lateral organization of endocytic machinery in dendritic spines. Nat Neurosci 7:917–918. https://doi.org/10.1038/nn1303 CrossRefPubMed

Rangaraju V, Calloway N, Ryan TA (2014) Activity-driven local ATP synthesis is required for synaptic function. Cell 156:825–835. https://doi.org/10.1016/j.cell.2013.12.042 CrossRefPubMedPubMedCentral

Reig-Viader R, Sindreu C, Bayés A (2018) Synaptic proteomics as a means to identify the molecular basis of mental illness: are we getting there? Prog Neuro-Psychopharmacol Biol Psychiatry 84:353–361. https://doi.org/10.1016/j.pnpbp.2017.09.011 CrossRef

Reis J, Cohen LG, Pearl PL et al (2012) GABAB-ergic motor cortex dysfunction in SSADH deficiency. Neurology 79:47–54. https://doi.org/10.1212/WNL.0b013e31825dcf71 CrossRefPubMedPubMedCentral

Roy M, Sorokina O, Skene N et al (2018) Proteomic analysis of postsynaptic proteins in regions of the human neocortex. Nat Neurosci 21:130–138. https://doi.org/10.1038/s41593-017-0025-9 CrossRefPubMed

Salomons GS, van Dooren SJM, Verhoeven NM et al (2003) X-linked creatine transporter defect: an overview. J Inherit Metab Dis 26:309–318CrossRefPubMed

Sheng M, Kim E (2011) The postsynaptic organization of synapses. Cold Spring Harb Perspect Biol 3:a005678–a005678. https://doi.org/10.1101/cshperspect.a005678 CrossRefPubMedPubMedCentral

Shepherd JD, Huganir RL (2007) The cell biology of synaptic plasticity: AMPA receptor trafficking. Annu Rev Cell Dev Biol 23:613–643CrossRefPubMed

Simpson IA, Carruthers A, Vannucci SJ (2007) Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J Cereb Blood Flow Metab 27:1766–1791. https://doi.org/10.1038/sj.jcbfm.9600521 CrossRefPubMed

Soto D, Altafaj X, Sindreu C, Bayés A (2014) Glutamate receptor mutations in psychiatric and neurodevelopmental disorders. Commun Integr Biol 7:e27887. https://doi.org/10.4161/cib.27887 CrossRefPubMedPubMedCentral

Spacek J (1985) Three-dimensional analysis of dendritic spines. II. Spine apparatus and other cytoplasmic components. Anat Embryol 171:235–243CrossRef

Steward O, Levy WB (1982) Preferential localization of polyribosomes under the base of dendritic spines in granule cells of the dentate gyrus. J Neurosci 2:284–291CrossRefPubMedPubMedCentral

Tarpey P, Parnau J, Blow M et al (2004) Mutations in the DLG3 gene cause nonsyndromic X-linked mental retardation. Am J Hum Genet 75:318–324. https://doi.org/10.1086/422703 CrossRefPubMedPubMedCentral

Volk L, Chiu S-L, Sharma K, Huganir RL (2015) Glutamate synapses in human cognitive disorders. Annu Rev Neurosci. https://doi.org/10.1146/annurev-neuro-071714-033821

von Bohlen Und Halbach O (2009) Structure and function of dendritic spines within the hippocampus. Ann Anat 191:518–531. https://doi.org/10.1016/j.aanat.2009.08.006 CrossRef

Wu K, Aoki C, Elste A et al (1997) The synthesis of ATP by glycolytic enzymes in the postsynaptic density and the effect of endogenously generated nitric oxide. Proc Natl Acad Sci U S A 94:13273–13278CrossRefPubMedPubMedCentral

Yuste R (2015) The discovery of dendritic spines by Cajal. Front Neuroanat 9:18. https://doi.org/10.3389/fnana.2015.00018 CrossRefPubMedPubMedCentral

Zehavi Y, Mandel H, Zehavi A et al (2017) De novo GRIN1 mutations: an emerging cause of severe early infantile encephalopathy. Eur J Med Genet 60:317–320. https://doi.org/10.1016/j.ejmg.2017.04.001 CrossRefPubMed

Title: Setting the stage for a role of the postsynaptic proteome in inherited neurometabolic disorders
Author: Àlex Bayés
Publication date: 01-11-2018
Publisher: Springer Netherlands
Published in: Journal of Inherited Metabolic Disease / Issue 6/2018
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI: https://doi.org/10.1007/s10545-018-0240-x

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Setting the stage for a role of the postsynaptic proteome in inherited neurometabolic disorders

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2018

Improvement in bone marrow infiltration in patients with type I Gaucher disease treated with taliglucerase alfa

Next-generation glycogen storage diseases

Severe ichthyosis in MPDU1-CDG

Correction to: Medical and financial burden of acute intermittent porphyria

Postsynaptic movement disorders: clinical phenotypes, genotypes, and disease mechanisms

Fibroblast growth factor 21 as a biomarker for long-term complications in organic acidemias

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page